Protocol EFC5555: Sub-Investigator, A Placebo controlled, Double-blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400mg bid for the Prevention of Cardiovascular Hospitalization or Death from any Cause in Patients with Atrial Fibrillation/At

Date: August 20, 2012|Source: No Source